Newsletter Signup x
We need to understand the long-term impact of treatments used for children who survive medulloblastoma. Forming a unique team of internationally-leading experts and future leaders will help to create a network prepared for the development and delivery of future clinical advances so we can better help children who suffer life-long side-effects of their disease and therapy.
SMILE: An International network for Medulloblastoma Survivorship and Late-Effects
Professor Steve Clifford
Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer
Newcastle upon Tyne, NE1 7RU
1 July 2022
36 months
£348,783.27
Why do second cancers occur within 5 years of diagnosis?
The dramatically increased survival rates for childhood cancer in recent decades, achieved largely through the use of increasingly intensive
Read more